drugset / Trial / NCT00460148

Parkinson's Disease Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole

NCT00460148

Phase 2 Completed 28 enrolled GlaxoSmithKline
RandomizedCrossoverOpen-labelTreatment

Summary

This study in PD patients is designed to assess the affect food has on the absorption, distribution, metabolism and excretion of ropinirole (by dosing some patients in the fasted state and other patients following a high-fat breakfast), and to assess the difference in absorption, distribution, metabolism and excretion of ropinirole if patients are given three 4mg ropinirole tablets versus one 12mg tablet.

Timeline

Start
2007-04
Primary completion
Completion
2007-08

Publications

  • Background This study has not been published in the scientific literature.

Drugs

EvaluationDrugModalityDoseRoute
Subject Ropinirole Small molecule 12 mg

Indications